| 1 |
APOE‐associated disease risk and sex‐specific effects in Egyptian Alzheimer's disease: an exploratory study |
2026 |
| 2 |
Physical disability, cognition, and depression as determinants of quality of life in multiple sclerosis: a cross-sectional study |
2026 |
| 3 |
Tracking the invisible: Impact of disease-modifying therapies on serum neurofilament light chain and clinical outcomes in treatment-naïve multiple sclerosis |
2026 |
| 4 |
A Prospective Study Of The Impact Of An Emotional Intelligence Program On Opioid Relapse And Its Determinants In Upper Egyptر |
2025 |
| 5 |
APOE genetic variability in an Egyptian cohort of PD |
2025 |
| 6 |
Biallelic variation in the choline and ethanolamine transporter FLVCR1 underlies a severe developmental disorder spectrum |
2025 |
| 7 |
Frequency and risk factors of sleep problems in Egyptian patients with multiple sclerosis |
2025 |
| 8 |
Frequency, Risk Factors, Sex Differences, and Predictors of Post-Stroke Depression: A Multicenter Upper Egypt Study |
2025 |
| 9 |
Mutations in the key autophagy tethering factor EPG5 link neurodevelopmental and neurodegenerative disorders including early‐onset parkinsonism |
2025 |
| 10 |
Nerve ultrasound as an adjunct to nerve conduction studies in Guillain–Barré syndrome diagnosis: a prospective Egyptian case–control study |
2025 |
هل لديك سؤال ؟
